Dr. Gok Yavuz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Hospital Dr
Columbia, MO 65212- Is this information wrong?
Education & Training
Hacettepe University FOMClass of 2018
Certifications & Licensure
MO State Medical License 2022 - 2025
Publications & Presentations
PubMed
- 94 citationsPerioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.Ahmed Omar Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean-Nicolas Vauthey
The Lancet. Gastroenterology & Hepatology. 2022-03-01 - 21 citationsCurrent Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma.Betul Gok Yavuz, Elshad Hasanov, Sunyoung S. Lee, Yehia I. Mohamed, Michael A. Curran
Journal of Hepatocellular Carcinoma. 2021-09-24 - 4 citationsSerum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellul...Ahmed O Kaseb, Yinghui Guan, Betul Gok Yavuz, Alexander R Abbas, Shan Lu
Journal of Hepatocellular Carcinoma. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
